Document Details
Form
Filing Date
Jan 11, 2024
Document Date
Jan 9, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
AN2 Therapeutics, Inc
Issuer
AN2 THERAPEUTICS, INC.
Filer
KRAUSE KEVIN MICHAEL
